Recent Activity

Loading...

AVTE

Aerovate Therapeutics, Inc. · NASDAQ

Performance

-4.59%

1W

-12.91%

1M

-1.63%

3M

+47.99%

6M

-9.1%

YTD

+5.7%

1Y

Profile

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Investment Analysis Report: AVTE

Overview

AVTE is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has shown significant growth in its financial metrics over the past three years. In this report, we will analyze AVTE's financial health, earnings and revenue growth, profitability, operat...

See more ...

Technical Analysis of AVTE 2024-05-10

Overview:

In analyzing the technical indicators for AVTE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide investment ...

See more ...

Recent News & Updates